People · Operator
Named in public records as an officer, director or promoter · active 2011–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clear Vascular, Inc. | — | Biotechnology | Series A | $8.9M | $11.2M | 2012 |
| Serene Oncology, LLC | — | Biotechnology | Seed | $1.8M | $12.0M | 2011 |
Jacques Krasny at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jacques Krasny on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Immanuel Thangaraj | 2 | 6 |
| Jim Dougherty | 2 | 2 |
| Gilbert Gonzales | 2 | 2 |
| Pat Patel | 1 | 1 |
| David W. Mueller | 1 | 1 |
| Jim W. Dougherty | 1 | 1 |
| Immanuel W. Thangaraj | 1 | 1 |
| Gilbert W. Gonzales | 1 | 1 |
| David Mueller | 1 | 1 |
| Gautam Patel | 1 | 1 |
| Tim McInerney | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.